3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Multiple Myeloma
6
Recurrence
4
Myelodysplastic Syndromes
4
Lymphoma, Non-Hodgkin
4
Leukemia, Myeloid, Acute
4
Breast Neoplasms
4
Prostatic Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasms
3
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Glioma
2
Diffuse Intrinsic Pontine Glioma
2
Carcinoma, Hepatocellular
2
Brain Neoplasms
2
Blast Crisis
2
Thrombocytosis
1
Stomach Neoplasms
1
Somatostatinoma
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Rhabdoid Tumor
1
Interventions
Capecitabine
27
pembrolizumab
19
Oxaliplatin
19
Fluorouracil
17
Cisplatin
17
Trastuzumab
14
Docetaxel
14
Leucovorin
11
Paclitaxel
8
Irinotecan
8
S 1 (combination)
7
Epirubicin
6
Cyclophosphamide
5
tegafur-gimeracil-oteracil
4
aldesleukin
4
Hyperthermic Intraperitoneal Chemotherapy
4
titanium silicide
3
spartalizumab
3
fludarabine phosphate
3
fludarabine
3
Surveys and Questionnaires
3
Surgical Procedures, Operative
3
Ramucirumab
3
Nivolumab
3
Indocyanine Green
3
Gemcitabine
3
Carboplatin
3
Albumin-Bound Paclitaxel
3
Ado-Trastuzumab Emtansine
3
vistusertib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Stomach Neoplasms
×
Panobinostat
×
Clear all
NCT01528501
2013-05-01
HDAC
Technical University of Munich
Phase 2
Terminated
28 enrolled